425 related articles for article (PubMed ID: 9467429)
1. Monocyte cytokine production in an elderly population: effect of age and inflammation.
Roubenoff R; Harris TB; Abad LW; Wilson PW; Dallal GE; Dinarello CA
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M20-6. PubMed ID: 9467429
[TBL] [Abstract][Full Text] [Related]
2. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
Liou LB
Clin Exp Rheumatol; 2001; 19(5):515-23. PubMed ID: 11579710
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.
Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM
Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146
[TBL] [Abstract][Full Text] [Related]
4. Cytokine antagonists in aged subjects and their relation with cellular immunity.
Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
[TBL] [Abstract][Full Text] [Related]
5. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.
Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA
Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322
[TBL] [Abstract][Full Text] [Related]
6. The association of peripheral monocyte derived interleukin 1beta (IL-1beta), IL-1 receptor antagonist, and tumor necrosis factor-alpha with osteoarthritis in the elderly.
Fraenkel L; Roubenoff R; LaValley M; McAlindon T; Chaisson C; Evans S; Harris T; Dinarello CA; Felson DT
J Rheumatol; 1998 Sep; 25(9):1820-6. PubMed ID: 9733466
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.
Drenth JP; Göertz J; Daha MR; van der Meer JW
Immunology; 1996 Jul; 88(3):355-62. PubMed ID: 8774350
[TBL] [Abstract][Full Text] [Related]
8. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells.
Gabay C; Genin B; Mentha G; Iynedjian PB; Roux-Lombard P; Guerne PA
Clin Exp Immunol; 1995 May; 100(2):306-13. PubMed ID: 7743670
[TBL] [Abstract][Full Text] [Related]
9. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood.
Schytte Blix IJ; Helgeland K; Hvattum E; Lyberg T
J Periodontal Res; 1999 Jan; 34(1):34-40. PubMed ID: 10086884
[TBL] [Abstract][Full Text] [Related]
12. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.
Tilg H; Vannier E; Vachino G; Dinarello CA; Mier JW
J Exp Med; 1993 Nov; 178(5):1629-36. PubMed ID: 7693853
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
Marsh CB; Wewers MD
Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.
Danis VA; Millington M; Hyland VJ; Grennan D
Clin Exp Immunol; 1995 Feb; 99(2):303-10. PubMed ID: 7851026
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
18. Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation.
Fantuzzi G; Sacco S; Ghezzi P; Dinarello CA
Am J Physiol; 1997 Jul; 273(1 Pt 2):R400-6. PubMed ID: 9249578
[TBL] [Abstract][Full Text] [Related]
19. Differences in interleukin 1 (IL-1), IL-6, tumor necrosis factor and IL-1 receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide.
Suzuki K; Torii K; Hida S; Hayashi H; Hiyama Y; Oomoto Y; Takii T; Chiba T; Onozaki K
Immunopharmacology; 1994; 28(1):31-8. PubMed ID: 7928300
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
Drenth JP; Krebbers RJ; Bijzet J; van der Meer JW
Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
